Governor says he might back a bill to require prescriptions for certain forms of pseudoephdrine
11/02/2011 10:00 PM
While not committing to any particular approach to address the scourge of methamphetamine, Gov. Steve Beshear said he’d be open to supporting a bill to require prescriptions for tablet forms of cold medicine with pseudoephedrine.
Pseudoephedrine, an ingredient in meth, has been targeted by some lawmakers. They want to make it more difficult for meth makers to get by requiring a prescription. Beshear hasn’t taken a side on that debate.
But he said on Pure Politics Monday that something must be done in the next session, it’s just a matter of what.
“What we’ve got right now is not adequate,” he said at the 5:30 mark of the video. “There’s some way we’ve got to do more.”
Democratic Rep. Linda Belcher of Shepherdsville said on Pure Politics in September that she would sponsor another bill to make pseudoephedrine a prescription but with an exemption for liquid capsules. It’s more difficult to make meth using liquid and gel forms of pseudoephedrine.
Beshear also talked about several proposals aimed at better tracking prescriptions and regulating pain clinics. (0:00 to 2:40)
Meanwhile, federal funds and grants are drying up for law enforcement and drug task forces. But Beshear said it remains unclear whether the state will find the resources to make up for that lost money.
“We’re going to do what we can under our budget restraints because this is a horrendous problem,” Beshear said at 3:00.
On the meth issue, the Healthcare Products Association has opposed making any forms of pseudoephedrine a prescription. Instead, it is pushing to tighten restrictions against convicted felons buying medication with that ingredient and further limiting the amount a person can buy each month.
Below the Fold
University of Louisville placed on one-year probation by accrediting agency after Bevin reshuffles board
Gov. Matt Bevin plays prominent speaking role at first Trump "USA Thank You Tour" event in Cincinnati
Subscribe and get the latest political intelligence delivered to your inbox.